These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16969731)

  • 61. Explantation of implantable defibrillator leads using open heart surgery or percutaneous techniques.
    Camboni D; Wollmann CG; Löher A; Gradaus R; Scheld HH; Schmid C
    Ann Thorac Surg; 2008 Jan; 85(1):50-5. PubMed ID: 18154777
    [TBL] [Abstract][Full Text] [Related]  

  • 62. NICE guidelines for use of implantable cardioverter defibrillators.
    Saberwal B; Ahsan S
    Br J Hosp Med (Lond); 2015 Jun; 76(6):316-7. PubMed ID: 26053899
    [No Abstract]   [Full Text] [Related]  

  • 63. The utility of a steerable long introducer sheath to facilitate left ventricular lead placement during a complex biventricular implantable cardioverter-defibrillator implant.
    Cohen TJ; Choi D
    J Invasive Cardiol; 2004 Oct; 16(10):600-1. PubMed ID: 15505361
    [No Abstract]   [Full Text] [Related]  

  • 64. [New indications for cardioverter-defibrillator implant: heart failure].
    Gaita F; Bocchiardo M; Padeletti L
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):571-3. PubMed ID: 12497785
    [No Abstract]   [Full Text] [Related]  

  • 65. Enhanced cardiac device management utilizing the random EGM: A neglected feature of remote monitoring.
    Ploux S; Eschalier R; Varma N; Ritter P; Klotz N; Haïssaguerre M; Bordachar P
    Heart Rhythm; 2016 Feb; 13(2):602-8. PubMed ID: 26432581
    [No Abstract]   [Full Text] [Related]  

  • 66. Can incremental innovation of implantable cardioverter-defibrillator systems become disruptive to patient care? Moore's law gone awry.
    Naccarelli GV
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):621-2. PubMed ID: 16836710
    [No Abstract]   [Full Text] [Related]  

  • 67. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
    Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Warner Stevenson L; Varosy PD; Welikovitch L
    Heart Rhythm; 2014 Jul; 11(7):1271-303. PubMed ID: 24819194
    [No Abstract]   [Full Text] [Related]  

  • 68. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of device therapy for ventricular arrhythmias.
    Holley LK
    Heart Lung Circ; 2007 Jun; 16(3):162-9. PubMed ID: 17446124
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy].
    van Gelder IC; Smit MD; Nieuwland W; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2238-44. PubMed ID: 17076357
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy.
    Reynolds MR; Josephson ME
    Circulation; 2003 Oct; 108(15):1779-83. PubMed ID: 14557341
    [No Abstract]   [Full Text] [Related]  

  • 73. Inappropriate shock: a failure of SVT discriminators in a dual chamber ICD?
    Al-Ahmad A; Tsiperfal A; Hsia HH; Wang PJ
    Pacing Clin Electrophysiol; 2006 Dec; 29(12):1413-5. PubMed ID: 17201851
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [ICD therapy 2005--from implantation to follow-up measures].
    Bänsch D; Kuck KH
    Herz; 2005 Nov; 30(7):589-90. PubMed ID: 16333582
    [No Abstract]   [Full Text] [Related]  

  • 76. Implantable cardioverter defibrillator therapy in athletes.
    Heidbüchel H
    Cardiol Clin; 2007 Aug; 25(3):467-82, vii. PubMed ID: 17961801
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treating AICD (automatic implantable cardioverter defibrillator) patients. Are you in for a shock?
    Wallace M
    JEMS; 1995 Feb; 20(2):59-61, 64. PubMed ID: 10141092
    [No Abstract]   [Full Text] [Related]  

  • 78. Appropriate result from an inappropriate ICD shock.
    Davis DR; Gollob MH; Green MS; Lemery R; Tang AS; Birnie DH
    Pacing Clin Electrophysiol; 2006 Oct; 29(10):1183-4. PubMed ID: 17038153
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate.
    Duray GZ; Israel CW; Pajitnev D; Hohnloser SH
    Europace; 2008 Jan; 10(1):48-52. PubMed ID: 18077483
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.